Jonathan Yong

Jonathan Young

Matt Hewitt

John French

John Pinney

Matthew Hewitt

Richard Close

- Clover Health's **2026 Medicare Advantage Star Ratings** were announced on **October 9, 2025**, with its PPO plans receiving **3.5 Stars** and its HMO plan receiving **4.0 Stars**, which will affect the payment year **2027**.  **[1801170_0001801170-25-000253_axex991xpressreleaseofthec.htm:0]** **[1801170_0001801170-25-000253_clov-20251009.htm:1]** 
- The company expects its **technology-centric business model** and **Clover Assistant platform** to **offset any effect from the Star ratings**, enabling continued **above-market membership growth** and **Adjusted EBITDA profitability expansion** through **2027**.  **[1801170_0001801170-25-000253_axex991xpressreleaseofthec.htm:0]** 
- For the first half of **2025**, Clover Health reported **34% year-over-year revenue growth** and **32% membership growth**, while achieving **sustained Adjusted EBITDA profitability**.  **[1801170_0001801170-25-000253_axex991xpressreleaseofthec.htm:0]** 
- Clover Health also highlighted its strong performance in **HEDIS clinical quality measures**, scoring **4.72 for its PPO plans**.  **[1801170_0001801170-25-000253_axex991xpressreleaseofthec.htm:0]**

Clover Health Comments on 2026 Medicare Advantage Star Ratings and 2027 Profitability Outlook

- The Centers for Medicare & Medicaid Services (CMS) awarded Clover Health's Medicare Advantage plans **3.5 Stars for PPO** and **4.0 Stars for HMO** for the 2026 Star ratings, which will affect the **payment year 2027**.  **[1801170_1d201a0c51bb46c2bde8f2af8824bb1e_0]** 
- Clover Health's CEO, Andrew Toy, stated that the company's technology-centric care strategy and AI-driven improvements in Clover Assistant position them to **offset any effect from the Star rating**.  **[1801170_1d201a0c51bb46c2bde8f2af8824bb1e_0]** 
- The company reiterates confidence in its ability to drive **above-market membership growth** and **increasing Adjusted EBITDA profitability through 2027**, independent of Star ratings.  **[1801170_1d201a0c51bb46c2bde8f2af8824bb1e_0]** 
- Through the first half of 2025, a 3.5 Star payment year, Clover grew **revenue by 34%** and **membership by 32% year-over-year** while delivering sustained Adjusted EBITDA profitability.  **[1801170_1d201a0c51bb46c2bde8f2af8824bb1e_0]**

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)